Michael Yang J.'s most recent trade in Ionis Pharmaceuticals Inc was a trade of 11,518 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 5,220 | 13,159 | - | - | Restricted Stock Unit | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 13,393 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 1,931 | 7,939 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 1,931 | 1,931 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Purchase of securities on an exchange or from another person at price $ 12.90 per share. | 14 Aug 2024 | 2,000 | 7,230 (0%) | 0% | 12.9 | 25,800 | Common Stock |
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 4,079 | 9,870 | - | - | Restricted Stock Unit | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 5,230 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Michael Yang J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 5,791 | 5,791 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Michael J. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 12,356 | 12,356 | - | - | Non-Qualified Stock Option (right to buy) | |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 2,722 | 8,167 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 2,722 | 9,179 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Sale of securities on an exchange or to another person at price $ 53.34 per share. | 06 Jan 2021 | 1,120 | 8,059 (0%) | 0% | 53.3 | 59,741 | Common Stock |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,500 | 5,000 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,500 | 7,704 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Michael J. Yang | EVP and CCO | Sale of securities on an exchange or to another person at price $ 42.56 per share. | 15 Oct 2020 | 1,247 | 6,457 (0%) | 0% | 42.6 | 53,072 | Common Stock |